Search

Search Constraints

You searched for: Author/Creator Desilva, A.

Search Results

4. Neoadjuvant Chemotherapy Resulting in Suboptimal CA19-9 Response is Associated with No Survival Benefit Compared to Surgery First Approach in Resectable or Borderline Resectable Pancreatic Cancer. (2022)